immune checkpoint inhibitors

Mesothelioma Immunotherapy diagram showing nivolumab and ipilimumab activating T-cells to attack pleural mesothelioma tumor in the lungs

Mesothelioma Immunotherapy: 2 New Drugs Saving Lives 2026

Nivolumab and ipilimumab have more than doubled 5-year mesothelioma survival rates. Discover who qualifies, real trial data, side effects, and 2026 treatment options.

Immunotherapy diagram showing T-cells attacking a tumor inside the human body

Immunotherapy: What It Is, How It Works & Who It Helps

Immunotherapy uses your immune system to fight cancer and allergies. Experts explain 7 types, real success rates, 2026 breakthroughs & whether it's right for you.